Ocugen (OCGN) Stock Price
$0.68 0%
to add to portfolio
AI Score

-
Alternative
10 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Ocugen, AI stock picks, stock alerts and much more.
OCGN AI Stock Analysis
AI stock analysis for OCGN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Ocugen (OCGN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Ocugen (OCGN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Ocugen (OCGN), currently trading at $0.68, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About OCGN

-
Ocugen, Inc.
-
Symbol
OCGN
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
197.8M
Similar Stocks
![]() |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
![]() |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
![]() |
Moderna MRNA |
$35.53 5.3% |
4 |
![]() |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
![]() |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
OCGN Alternative Data
Web Traffic
Ocugen receives an estimated 29074 monthly visitors to ocugen.com.
-
Web Traffic
29074
-
Change from Previous Month
59.6%
-
3 Month Change
149.3%
-
YoY Change
149.3%
News Mentions
Ocugen was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Ocugen has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
Twitter Followers
Ocugen has 52,762 Twitter Followers on its main Twitter (also known as X) account, which is up by 1% over the last month.
-
Twitter Followers
52762
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
2.4%
-
YoY Change
2.4%
LinkedIn Followers
14,362 are following Ocugen on LinkedIn, up by 2.2% over the last month.
-
LinkedIn Followers
14362
-
Daily Change
0%
-
1 Month Change
2.2%
-
3 Month Change
5.3%
Job Postings
Ocugen currenly has an estimated 6 open job postings.
-
Job Postings
6
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Ocugen has 88 employees, up by 8.6% over the last month.
-
LinkedIn Employees
88
-
Daily Change
0%
-
1 Month Change
8.6%
-
3 Month Change
14.3%
-
YoY Change
14.3%
Business Outlook
-
Business Outlook
29
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
OCGN Financials
OCGN Key Metrics
-
Total Revenue
$1.1M
-
Net Income
-$13M
-
Earnings per Share
-$0.0447
-
Free cash flow
-$11.8M
-
EBITDA
-$12.6M
-
EBITDA Ratio
-11.1259
-
Total Assets
$61.9M
OCGN 2-year Revenue & Income
OCGN 2-year Free Cash Flow
OCGN Technicals
OCGN SMA
OCGN RSI
FAQ
What's the current price of Ocugen (OCGN) Stock?
The price of an Ocugen (OCGN) share is $0.68.
What's the market cap of Ocugen?
The current market cap of Ocugen is 197.8M.
Should I buy or sell OCGN?
Ocugen shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Ocugen is better viewed as a hold or accumulate position while waiting for further developments.
Is Ocugen a good investment?
The current analysis of Ocugen's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Ocugen's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Ocugen (OCGN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Ocugen stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Ocugen (OCGN) that investors often compare it to?
Ocugen (OCGN) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Ocugen's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Ocugen's stock price to be around $0.68 in 2026. Starting from the current price of $0.68, this represents a 0% change in price, indicating a neutral outlook for the stock.
How to buy Ocugen (OCGN) Stock?
Ocugen stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Ocugen shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.